Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Drugs alphabetical "x", total number of products: 85
Reg.‑No.
Product
Composition
A
|
B
|
C
|
D
|
E
|
F
|
G
|
H
|
I
|
J
|
K
|
L
|
M
|
N
|
O
|
P
|
Q
|
R
|
S
|
T
|
U
|
V
|
W
|
X
|
Y
|
Z
|
0-9
1 - 85
34302
IP
CI
X-Prep
Solution (oral): Sennae Fructus Extractum Aquosum Siccum
G
65360
IP
CI
Xadago 100 mg
compresse rivestite con film: Safinamidum 100 mg
G
65360
IP
CI
Xadago 50 mg
compresse rivestite con film: Safinamidum 50 mg
G
54720
IP
CI
Xagrid 0,5 mg
Capsules: Anagrelidum
G
55612
IP
CI
Xalacom
Eye drops: 2 Active Agents
G
53675
IP
CI
Xalatan
G
62131
IP
CI
Xalkori 200 mg
Capsules: Crizotinibum 200 mg
G
62131
IP
CI
Xalkori 250 mg
Capsules: Crizotinibum 250 mg
G
65371
IP
CI
Xaluprine 20 mg/ml
Suspension (oral): Mercaptopurinum Monohydricum 20 mg/ml
G
58786
IP
CI
Xamiol
Gel: 2 Active Agents
G
43216
IP
CI
Xanax 0,25 mg
Tablets: Alprazolamum
G
43216
IP
CI
Xanax 0,5 mg
Tablets: Alprazolamum
G
43216
IP
CI
Xanax 1 mg
Tablets: Alprazolamum 1 mg
G
43216
IP
CI
Xanax 2 mg
Tablets: Alprazolamum 2 mg
G
52866
IP
CI
Xanax retard 0,5 mg
Tablets: Alprazolamum
G
52866
IP
CI
Xanax retard 1 mg
Tablets: Alprazolamum 1 mg
G
52866
IP
CI
Xanax retard 2 mg
Tablets: Alprazolamum 2 mg
G
52866
IP
CI
Xanax retard 3 mg
Tablets: Alprazolamum 3 mg
G
58728
IP
CI
Xarelto 10 mg
Coated tablets: Rivaroxabanum 10 mg
G
58728
IP
CI
Xarelto 15 mg
Coated tablets: Rivaroxabanum 15 mg
G
58728
IP
CI
Xarelto 20 mg
Coated tablets: Rivaroxabanum 20 mg
G
67701
IP
CI
Xarelto junior
Granulat zur Herstellung einer Suspension zum Einnehmen: Rivaroxabanum 1 mg
G
66872
IP
CI
Xarelto vascular 2,5 mg
Coated tablets: Rivaroxabanum 2.5 mg
G
50205
IP
CI
Xatral 2,5 mg
Coated tablets: Alfuzosini Hydrochloridum 2.5 mg
G
55188
IP
CI
Xatral uno
Delayed release tablets: Alfuzosini Hydrochloridum 10 mg
G
62630
IP
CI
Xeljanz 10 mg
Coated tablets: Tofacitinibum 10 mg
G
62630
IP
CI
Xeljanz 5 mg
Coated tablets: Tofacitinibum 5 mg
G
54657
IP
CI
Xeloda 150 mg
Coated tablets: Capecitabinum 150 mg
G
54657
IP
CI
Xeloda 500 mg
Coated tablets: Capecitabinum 500 mg
G
58375
IP
CI
Xenazine
Tablets: Tetrabenazinum 25 mg
G
53001
IP
Xenetix 300 mg
Injection solution: Iobitridolum 658.1 mg/ml
G
53001
IP
Xenetix 350 mg
Injection solution: Iobitridolum 767.8 mg/ml
G
54282
IP
CI
Xenical
Capsules: Orlistatum 120 mg
G
62080
IP
Xeomin 100 LD50-Einheiten
Dry substance: Toxinum Botulinicum a (150 Kda) 100 UI
G
62080
IP
Xeomin 200 LD50-Einheiten
Dry substance: Toxinum Botulinicum a (150 Kda) 200 UI
G
62080
IP
Xeomin 50 LD50-Einheiten
Dry substance: Toxinum Botulinicum a (150 Kda) 50 UI
G
60466
IP
Xeplion 100 mg
Retardsuspension zur intramuskulären Injektion: Paliperidonum 100 mg
G
60466
IP
Xeplion 150 mg
Retardsuspension zur intramuskulären Injektion: Paliperidonum 150 mg
G
60466
IP
Xeplion 25 mg
Retardsuspension zur intramuskulären Injektion: Paliperidonum 25 mg
G
60466
IP
Xeplion 50 mg
Retardsuspension zur intramuskulären Injektion: Paliperidonum 50 mg
G
60466
IP
Xeplion 75 mg
Retardsuspension zur intramuskulären Injektion: Paliperidonum 75 mg
G
66374
IP
CI
Xermelo 250 mg
Coated tablets: Ethylis Telotristatas 250 mg
G
68471
IP
Xevudy
Concentrate for infusion: Sotrovimabum 500mg / 8ml
G
61865
IP
XGEVA 120 mg
Injection solution: Denosumabum 120mg / 1.7ml
G
63216
IP
CI
Xifaxan 550 mg
Coated tablets: Rifaximinum 550 mg
G
65377
IP
CI
Xigduo XR 10 mg / 1000 mg
Coated tablets: 2 Active Agents
G
65377
IP
CI
Xigduo XR 10 mg / 500 mg
Coated tablets: 2 Active Agents
G
65377
IP
CI
Xigduo XR 5 mg / 1000 mg
Coated tablets: 2 Active Agents
G
65377
IP
CI
Xigduo XR 5 mg / 500 mg
Coated tablets: 2 Active Agents
G
62732
IP
Xofigo 1100 kBq/ml Ra-223-Dichlorid
Injection solution: Radii(223-Ra) Dichloridum zum Kalibrierungszeitpunkt 6600
G
68068
IP
CI
Xofluza 2 mg / ml
Granulat zur Herstellung einer Suspension zum Einnehmen: Baloxavirum Marboxilum 40 mg
G
67426
IP
CI
Xofluza 20 mg
Coated tablets: Baloxavirum Marboxilum 20 mg
G
67426
IP
Xofluza 40 mg
Coated tablets: Baloxavirum Marboxilum 40 mg
G
67426
IP
Xofluza 80 mg
Coated tablets: Baloxavirum Marboxilum 80 mg
G
57178
IP
CI
Xolair 150 mg
Lyophilisate and solvent: Omalizumabum 150 mg
G
68030
IP
Xolair 150 mg/1.0 ml
Injection solution in prefilled syringe: Omalizumabum 150mg / 1ml
G
57178
IP
CI
Xolair 75 mg
Lyophilisate and solvent: Omalizumabum 75 mg
G
68030
IP
CI
Xolair 75 mg/0.5 ml
Injection solution in prefilled syringe: Omalizumabum 75mg / 0.5ml
G
68868
Xonvea 10 mg / 10 mg
Gastric juice resistant tablets: 2 Active Agents
G
67643
IP
Xorox 30 mg/g
Ophtalmic ointment: Aciclovirum 30 mg
G
67211
IP
CI
Xospata 40 mg
Coated tablets: Gilteritinibum 40 mg
G
67236
IP
CI
Xtandi 40 mg
Coated tablets: Enzalutamidum 40 mg
G
67236
IP
Xtandi 80 mg
Coated tablets: Enzalutamidum 80 mg
G
65041
IP
CI
Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml
Injection solution: 3 Active Agents
G
23706
IP
Xylesin 10 mg/ml
Injection solution: Lidocaini Hydrochloridum Monohydricum 10 mg/ml
G
23706
IP
Xylesin 20 mg/ml
Injection solution: Lidocaini Hydrochloridum Monohydricum 20 mg/ml
G
23706
IP
Xylesin mit Konservans 10 mg/ml
Injection solution: Lidocaini Hydrochloridum Monohydricum 10 mg/ml
G
23706
IP
Xylesin mit Konservans 20 mg/ml
Injection solution: Lidocaini Hydrochloridum Monohydricum 20 mg/ml
G
23706
IP
Xylesin mit Konservans 5 mg/ml
Injection solution: Lidocaini Hydrochloridum Monohydricum 5 mg/ml
G
67973
IP
CI
Xylo Dexpanthenol Spirig HC
Nasal spray: 2 Active Agents
G
68563
IP
CI
Xylo Zentiva Nasenspray 0.05%
Nasal spray: Xylometazolini Hydrochloridum
G
68563
IP
Xylo Zentiva Nasenspray 0.1%
Nasal spray: Xylometazolini Hydrochloridum 1 mg/ml/ml
G
62745
IP
CI
Xylo-Acino 0.05 %
Nasal spray: Xylometazolini Hydrochloridum
G
62745
IP
CI
Xylo-Acino 0.1 %
Nasal spray: Xylometazolini Hydrochloridum 1 mg/ml/ml
G
57259
IP
CI
Xylo-Mepha 0.05%
Nasal spray: Xylometazolini Hydrochloridum
G
57259
IP
CI
Xylo-Mepha 0.1%
Nasal spray: Xylometazolini Hydrochloridum 1 mg/ml
G
65868
IP
CI
Xylo-Mepha Plus
Nasal spray: 2 Active Agents
G
52094
IP
Xylocain 20 mg/g
Gel: Lidocaini Hydrochloridum Anhydricum 20 mg
G
52097
IP
Xylocain
Spray: Lidocainum 10 mg
G
66758
IP
CI
Xylofelan 0.1%
Nasal spray: Xylometazolini Hydrochloridum 1 mg/ml
G
68892
IP
CI
Xylofelan Plus
Nasenspray Lösung: 2 Active Agents
G
42773
IP
Xyloneural
Injection solution: Lidocaini Hydrochloridum Anhydricum 10 mg
G
57184
IP
CI
Xyrem 500 mg/ml
Solution (oral): Natrii Oxybas 500 mg
G
55754
IP
CI
Xyzal
Coated tablets: Levocetirizini Dihydrochloridum 5 mg
G
56711
IP
CI
Xyzal
Drops: Levocetirizini Dihydrochloridum 5 mg/ml
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2023
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home